Menu Search
Equities

Nyxoah SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert
5YI:FRA

Nyxoah SA

Actions
  • Price (EUR)3.81
  • Today's Change-0.005 / -0.13%
  • Shares traded245.00
  • 1 Year change-63.54%
  • Beta0.6672
Data delayed at least 15 minutes, as of Feb 11 2026 08:55 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

  • Revenue in EUR (TTM)5.64m
  • Net income in EUR-83.72m
  • Incorporated2009
  • Employees184.00
  • Location
    Nyxoah SARue Edouard Belin 12MONT-SAINT-GUIBERT 1435BelgiumBEL
  • Phone+32 26121755
  • Fax+32 10459075
  • Websitehttps://www.nyxoah.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.